By Josée Rose
Biote said Chief Executive Officer Terry Weber is expected to retire effective Feb. 1, and would be succeeded by Bret Christensen.
The hormone- and therapeutic-health and wellness company said Weber will advise the company's board of directors.
Christensen has over two decades of leadership experience in the healthcare industry, Biote said, and has worked at Hologic, Myriad Genetics and Insulet.
Write to Josée Rose at josee.rose@wsj.com
(END) Dow Jones Newswires
January 30, 2025 16:47 ET (21:47 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.